The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...
This has raised concerns about what will happen to the troves of genetic data it has in its possession. The company’s chief ...
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
The firm expects to save more than $35 million in annualized costs through the restructuring. CEO Anne Wojcicki told ...
11hon MSN
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0616 GMT – Mega Lifesciences is facing pressure from a ...
Newser on MSN14h
Amid 'Substantial Doubt,' 23andMe Cuts 40% of WorkersThe genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...
Good day and thank you for standing by. Welcome to the 23andMe fiscal year 2025 2nd quarter earnings call at this time. All participants are in listen-only mode. Please be advised that this call is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback